Increased risk of bleeding with the use of tipranavir boosted with ritonavir in haemophilic patients.
Arbuthnot
C
C
Wilde
J T
JT
D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy; D006467:Hemophilia A / Q000150:complications* / Q000188:drug therapy; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D011725:Pyridines / Q000009:adverse effects*; D011753:Pyrones / Q000009:adverse effects*; D012306:Risk; D019438:Ritonavir / Q000009:adverse effects*; D013449:Sulfonamides
D011725:Pyridines; D011753:Pyrones; D013449:Sulfonamides; D019438:Ritonavir; C107201:tipranavir